Sareum Holdings plc (AIM:SAR)
London · Delayed Price · Currency is GBP · Price in GBX 22.30
+1.80 (8.78%)
Sep 2, 2025, 4:15 PM GMT+1
Sareum Holdings Market Cap
Sareum Holdings has a market cap or net worth of 30.19 million as of September 2, 2025. Its market cap has decreased by -6.78% in one year.
Market Cap
30.19M
Enterprise Value
26.04M
Revenue
n/a
Ranking
n/a
PE Ratio
n/a
Stock Price
22.30
Market Cap Chart
Since December 6, 2004, Sareum Holdings's market cap has increased from 8.69M to 30.19M, an increase of 247.24%. That is a compound annual growth rate of 6.18%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Sep 2, 2025 | 30.19M | -1.37% |
| Dec 31, 2024 | 30.61M | -26.79% |
| Dec 29, 2023 | 41.81M | -25.56% |
| Dec 30, 2022 | 56.16M | -66.33% |
| Dec 31, 2021 | 166.77M | 110.46% |
| Dec 31, 2020 | 79.24M | 626.77% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| AstraZeneca | 184.59B |
| GSK plc | 58.11B |
| Haleon | 32.30B |
| Smith & Nephew | 12.07B |
| ConvaTec Group | 4.86B |
| Hikma Pharmaceuticals | 3.94B |
| HUTCHMED (China) | 1.87B |
| Genus | 1.70B |